Cost Effectiveness of Sirolimus Eluting Stents vs. Vasculary Brachytherapy for In-Stent Restenosis: Results from the SISR Trial
Cost Effectiveness of Sirolimus Eluting Stents vs. Vasculary Brachytherapy for In-Stent Restenosis: Results from the SISR Trial. American Heart Association's 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke. 2007.